Anebulo raises $6.6M in private placement of common shares and warrants

Anebulo Pharmaceuticals, Inc.

Sold 2,264,650 units at $2.935 each for aggregate proceeds of ~$6.6 million; each unit consists of one share and one warrant.
Warrants exercisable at $4.215 per share, immediately exercisable, five-year term; beneficial ownership limitation applies.
22NW Fund, LP, an affiliate of director Aron English, purchased 1,703,577 units for ~$5.0 million.
Net proceeds to advance development of ANEB-001 (acute cannabinoid intoxication) and for general corporate purposes.
MTS Securities acted as placement agent; fee of 6% of gross proceeds (1% for 22NW participation) plus expenses.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.